Kunkel Lori Anne

CIK 00015363687 companiesBOULDER, CO

SEC Profile

Transactions

Companies

Filings

CIK

0001536368

Recent Transactions

50 trades

Award
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2026-02-12+17,126→ 17,126 total
Award
Oric Pharmaceuticals, Inc.$ORIC
Stock Option (right to buy)
2026-01-02+40,000→ 40,000 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-12-17$1.12/sh+15,958→ 30,712 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2025-12-17−15,958→ 3,741 total
Exercise/Conversion
Oric Pharmaceuticals, Inc.$ORIC
Stock Option (right to buy)
2025-12-08−10,000→ 15,600 total
Exercise/Conversion
Oric Pharmaceuticals, Inc.$ORIC
Common Stock
2025-12-08$7.90/sh+10,000→ 84,200 total
Exercise/Conversion
Oric Pharmaceuticals, Inc.$ORIC
Stock Option (right to buy)
2025-12-04−5,534→ 0 total
Exercise/Conversion
Oric Pharmaceuticals, Inc.$ORIC
Common Stock
2025-12-04$3.75/sh+5,534→ 74,200 total
Award
Nurix Therapeutics, Inc.$NRIX
Director Stock Option (right to buy)
2025-05-19+25,000→ 25,000 total
Exercise/Conversion
Oric Pharmaceuticals, Inc.$ORIC
Common Stock
2025-03-03$6.33/sh+20,500→ 68,666 total
Exercise/Conversion
Oric Pharmaceuticals, Inc.$ORIC
Stock Option (right to buy)
2025-03-03−27,666→ 5,534 total
Exercise/Conversion
Oric Pharmaceuticals, Inc.$ORIC
Common Stock
2025-03-03$3.75/sh+27,666→ 48,166 total
Exercise/Conversion
Oric Pharmaceuticals, Inc.$ORIC
Stock Option (right to buy)
2025-03-03−20,500→ 0 total
Award
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2025-02-06+15,368→ 15,368 total
Award
Oric Pharmaceuticals, Inc.$ORIC
Stock Option (right to buy)
2025-01-02+35,000→ 35,000 total
Gift
Nurix Therapeutics, Inc.$NRIX
Common Stock
2024-07-17−54,027→ 0 total
Award
Oric Pharmaceuticals, Inc.$ORIC
Stock Option (right to buy)
2024-06-12+25,600→ 25,600 total
Exercise/Conversion
Oric Pharmaceuticals, Inc.$ORIC
Stock Option (right to buy)
2024-06-03−20,500→ 33,200 total
Exercise/Conversion
Oric Pharmaceuticals, Inc.$ORIC
Common Stock
2024-06-03$3.75/sh+20,500→ 20,500 total
Award
Nurix Therapeutics, Inc.$NRIX
Director Stock Option (right to buy)
2024-05-20+25,000→ 25,000 total
Award
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2024-04-08+37,882→ 37,882 total
Award
Oric Pharmaceuticals, Inc.$ORIC
Stock Option (right to buy)
2023-06-14+20,500→ 20,500 total
Award
Nurix Therapeutics, Inc.$NRIX
Director Stock Option (right to buy)
2023-05-04+25,000→ 25,000 total
Award
Oric Pharmaceuticals, Inc.$ORIC
Stock Option (right to buy)
2022-06-17+53,700→ 53,700 total
Award
Nurix Therapeutics, Inc.$NRIX
Director Stock Option (right to buy)
2022-05-05+17,500→ 17,500 total
Award
CURIS INC$CRIS
Non Qualified Stock Option
2022-01-31+85,000→ 85,000 total
Award
Oric Pharmaceuticals, Inc.$ORIC
Stock Option (right to buy)
2021-06-16+16,625→ 16,625 total
Award
Nurix Therapeutics, Inc.$NRIX
Director Stock Option (right to buy)
2021-05-06+17,500→ 17,500 total
Award
CURIS INC$CRIS
Non Qualified Stock Option
2021-01-28+33,000→ 33,000 total
Award
Oric Pharmaceuticals, Inc.$ORIC
Stock Option (right to buy)
2020-06-09+28,515→ 28,515 total
Award
CURIS INC$CRIS
Non Qualified Stock Option
2020-03-02+180,000→ 180,000 total
Award
Forte Biosciences, Inc.$FBRX
Stock Option (right to buy)
2019-10-04+7,500→ 7,500 total
Award
Forte Biosciences, Inc.$FBRX
Stock option (right to buy)
2019-05-29+20,000→ 20,000 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−4,716→ 0 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−8,750→ 0 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−27,344→ 0 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−49,687→ 0 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−3,095→ 0 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−11,000→ 0 total
Sale
CURIS INC$CRIS
Common Stock
2019-01-23$1.05/sh−14,800→ 22,200 total
Award
CURIS INC$CRIS
Non Qualified Stock Option
2019-01-21+180,000→ 180,000 total
Award
Forte Biosciences, Inc.$FBRX
Stock option (right to buy)
2019-01-11+35,000→ 35,000 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-10-01$171.90/sh−500→ 0 total
Exercise/Conversion
Loxo Oncology, Inc.
Common Stock
2018-10-01$3.65/sh+5,000→ 5,000 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-10-01$170.20/sh−4,500→ 500 total
Exercise/Conversion
Loxo Oncology, Inc.
Director Stock Option (Right to Buy)
2018-10-01−5,000→ 22,344 total
Award
Forte Biosciences, Inc.$FBRX
Stock option (right to buy)
2018-06-21+20,000→ 20,000 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-06-15$177.79/sh−4→ 0 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-06-15$177.12/sh−5,601→ 4 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-06-15$175.64/sh−1,235→ 5,605 total

Kunkel Lori Anne

Recent Transactions

Companies

Recent Filings

Address